Skip to main content

Peer Review reports

From: Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials

Original Submission
2 Nov 2023 Submitted Original manuscript
31 Dec 2023 Reviewed Reviewer Report
5 Jan 2024 Reviewed Reviewer Report
9 Jan 2024 Author responded Author comments - Francisco Cezar Aquino de Moraes
Resubmission - Version 2
9 Jan 2024 Submitted Manuscript version 2
18 Jan 2024 Reviewed Reviewer Report
24 Jan 2024 Reviewed Reviewer Report
27 Jan 2024 Author responded Author comments - Francisco Cezar Aquino de Moraes
Resubmission - Version 3
27 Jan 2024 Submitted Manuscript version 3
5 Feb 2024 Author responded Author comments - Francisco Cezar Aquino de Moraes
Resubmission - Version 4
5 Feb 2024 Submitted Manuscript version 4
Publishing
7 Feb 2024 Editorially accepted
21 Feb 2024 Article published 10.1186/s12885-024-11980-w

You can find further information about peer review here.

Back to article page